Bold Science. Breakthrough Medicine. | Knopp Biosciences
Knopp Biosciences is a drug discovery and development company focused on delivering breakthrough treatments in neurological disorders through innovation, experience and partnership. Knopp?s lead compound, KNS-760704, is currently in clinical development for amyotrophic lateral sclerosis, with additional indications under investigation.
James Bennett MD, Jim Bennett, Merit Cudkowicz MD, Arimoclomol, Cytrx, Trophos,mitochondria, pramipexole, neurodegeneration, neuroprotection, SLA, Charcot, motorneuron, dexpramipexole, Lou Gehrig, ALSA, ALSTDI, MNDA, MDA, SMA, Biogen, Biogen Idec
Last Update: MEZ/CET 23.07.2017, 06:05:26 Uhr